상세 보기
자료 필터
자료유형
발행연도
2025 ~ 2025
2025 2025
키워드
언어
전체 3건 중 1번부터 3번까지의 결과를 표시합니다.
2025
Article
Genomic and transcriptomic analyses of residual invasive triple-negative breast cancer after neoadjuvant chemotherapy in the prospective MIRINAE trial (a randomized phase II trial of adjuvant atezolizumab plus capecitabine compared to capecitabine; KCSG-BR18-21)
- Im, S. A. ;
- Park, K. ;
- Koh, J. ;
- Park, C. ;
- Jung, K. H. ;
- ... Bae, J. ;
- 외 29명
- 2025-10
- ESMO OPEN
- ELSEVIER
Article
Randomized, phase II trial to evaluate the efficacy and safety of atezolizumab plus capecitabine adjuvant therapy compared to capecitabine monotherapy for triple receptor-negative breast cancer with residual invasive cancer after neoadjuvant chemotherapy (MIRINAE trial, KCSG-BR18-21)
- Lee, Jieun ;
- Ahn, Hee Kyung ;
- Lee, Kyung-Hun ;
- Jung, Kyung Hae ;
- Park, Yeon Hee ;
- ... Bae, Jihong ;
- 외 23명
- 2025-08
- BMC Cancer
- BMC
Article
Efficacy and Safety of a 3-Weekly TS-1 Adjuvant Regimen in Advanced Gastric Cancer: A Pilot Study
- Bae, Jihong ;
- Park, Joo-Hwan ;
- Kim, Young Saing ;
- Ahn, Hee Kyung ;
- Cho, Eun Kyung ;
- ... Park, Ji-Hyeon ;
- ... Yang, Jun-Young ;
- ... Lee, Woon Kee ;
- ... Sym, Sun Jin ;
- 외 1명
- 2025-07
- Cancer Medicine
- WILEY